Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5821)
All Articles published online
|
Publishing Process of This Article
|
Aug 6, 2013 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Beales ILP, Hensley A, Loke Y. Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition. World J Gastrointest Pharmacol Ther 2013; 4(3): 69-79 [PMID: 23919219 DOI: 10.4292/wjgpt.v4.i3.69] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v4/i3/69.htm |
| Number | Citing Articles |
| 1 |
Mark R. Wendling, Brant K. Oelschlager. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; : 339 doi: 10.1016/B978-0-323-40232-3.00033-9
|
| 2 |
Oliver J. Old, L. Max Almond, Hugh Barr, Janusz Jankowski. Esophageal Cancer. 2015; : 83 doi: 10.1007/978-3-319-20068-2_5
|
| 3 |
Laura Galli, Vincenzo Spagnuolo, Andrea Poli, Stefania Salpietro, Nicola Gianotti, Francesca Cossarini, Alessia Carbone, Silvia Nozza, Simona Bossolasco, Alba Bigoloni, Adriano Lazzarin, Antonella Castagna. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy. AIDS 2014; 28(16): 2407 doi: 10.1097/QAD.0000000000000443
|
| 4 |
Sarang Jang, Hyo Geun Choi, Mi Jung Kwon, Ji Hee Kim, Joo-Hee Kim, So Young Kim. Relation of Statin Use with Esophageal Cancer. Pharmaceuticals 2023; 16(6): 900 doi: 10.3390/ph16060900
|
| 5 |
Parisa Karimi, Farhad Islami, Sharmila Anandasabapathy, Neal D. Freedman, Farin Kamangar. Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention. Cancer Epidemiology, Biomarkers & Prevention 2014; 23(5): 700 doi: 10.1158/1055-9965.EPI-13-1057
|
| 6 |
Qi-Jun Wu, Chao Tu, Yuan-Yuan Li, Jingjing Zhu, Ke-Qing Qian, Wen-Jing Li, Lang Wu. Statin use and breast cancer survival and risk: a systematic review and meta-analysis. Oncotarget 2015; 6(40): 42988 doi: 10.18632/oncotarget.5557
|
| 7 |
Pavana Thomas, Annapurna Pranatharthi, Cecil Ross, Sweta Srivastava. RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1327-4
|
| 8 |
Jonathan V. S. Wong, Ali Fatehi Hassanabad. Targeting the Mevalonate Pathway for Treating Esophageal Cancer. Journal of Gastrointestinal Cancer 2021; 52(2): 819 doi: 10.1007/s12029-021-00644-8
|
| 9 |
Simona Pisanti, Paola Picardi, Elena Ciaglia, Alba D’Alessandro, Maurizio Bifulco. Novel prospects of statins as therapeutic agents in cancer. Pharmacological Research 2014; 88: 84 doi: 10.1016/j.phrs.2014.06.013
|
| 10 |
Annapurna Pranatharthi, Cecil Ross, Sweta Srivastava, Zhi Sheng. Cancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea Attention. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/5785786
|
| 11 |
Stefanos Bonovas. Statins: Do They Have a Potential Role in Cancer Prevention and Modifying Cancer-Related Outcomes?. Drugs 2014; 74(16): 1841 doi: 10.1007/s40265-014-0309-2
|
| 12 |
Aleksandra M. Urbanska, Selvarangan Ponnazhagan, Masoud Mozafari. Pathology, Chemoprevention, and Preclinical Models for Target Validation in Barrett Esophagus. Cancer Research 2018; 78(14): 3747 doi: 10.1158/0008-5472.CAN-18-0206
|
| 13 |
Katie E O’Sullivan, James J Phelan, Ciara O’Hanlon, Joanne Lysaght, Jacintha N O’Sullivan, John V Reynolds. The role of inflammation in cancer of the esophagus. Expert Review of Gastroenterology & Hepatology 2014; 8(7): 749 doi: 10.1586/17474124.2014.913478
|
| 14 |
O J Old, L M Almond, H Barr. Barrett's oesophagus: how should we manage it?. Frontline Gastroenterology 2015; 6(2): 108 doi: 10.1136/flgastro-2014-100552
|
| 15 |
Wanqing Chen, Rongshou Zheng, Siwei Zhang, Hongmei Zeng, Yaguang Fan, Youlin Qiao, Qinghua Zhou. Esophageal cancer incidence and mortality in China, 2010. Thoracic Cancer 2014; 5(4): 343 doi: 10.1111/1759-7714.12100
|
| 16 |
Elizabeth Long, Ian L.P. Beales. The role of obesity in oesophageal cancer development. Therapeutic Advances in Gastroenterology 2014; 7(6): 247 doi: 10.1177/1756283X14538689
|
| 17 |
Yanfang Qiu, Jie You, Kunlun Wang, Yuan Cao, Youchun Hu, Han Zhang, Rong Fu, Yafei Sun, Huanan Chen, Ling Yuan, Quanjun Lyu. Effect of whole-course nutrition management on patients with esophageal cancer undergoing concurrent chemoradiotherapy: A randomized control trial. Nutrition 2020; 69: 110558 doi: 10.1016/j.nut.2019.110558
|
| 18 |
Theresa Nguyen, Zhigang Duan, Aanand D. Naik, Jennifer R. Kramer, Hashem B. El-Serag. Statin Use Reduces Risk of Esophageal Adenocarcinoma in US Veterans With Barrett’s Esophagus: A Nested Case-Control Study. Gastroenterology 2015; 149(6): 1392 doi: 10.1053/j.gastro.2015.07.009
|
| 19 |
Jan Martínek, Jun‐ichi Akiyama, Zuzana Vacková, Manuele Furnari, Edoardo Savarino, Teus J. Weijs, Elen Valitova, Sylvia van der Horst, Jelle P. Ruurda, Lucas Goense, George Triadafilopoulos. Current treatment options for esophageal diseases. Annals of the New York Academy of Sciences 2016; 1381(1): 139 doi: 10.1111/nyas.13146
|
| 20 |
L. Max Almond, Oliver Old, Hugh Barr. Strategies for the prevention of oesophageal adenocarcinoma. International Journal of Surgery 2014; 12(9): 931 doi: 10.1016/j.ijsu.2014.07.273
|
| 21 |
Tom Thomas, Yoon Loke, Ian L. P. Beales. Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Oesophageal Adenocarcinoma. Journal of Gastrointestinal Cancer 2018; 49(4): 442 doi: 10.1007/s12029-017-9983-0
|
| 22 |
Chris R. Cardwell, Andrew D. Spence, Carmel M. Hughes, Liam J. Murray. Statin use after esophageal cancer diagnosis and survival: A population based cohort study. Cancer Epidemiology 2017; 48: 124 doi: 10.1016/j.canep.2017.04.015
|
| 23 |
Michael J. Gonyeau. The Spectrum of Statin Therapy in Cancer Patients: Is There a Need for Further Investigation?. Current Atherosclerosis Reports 2014; 16(1) doi: 10.1007/s11883-013-0383-z
|
| 24 |
Su Liu, Harpreet Uppal, Marco Demaria, Pierre-Yves Desprez, Judith Campisi, Pankaj Kapahi. Simvastatin suppresses breast cancer cell proliferation induced by senescent cells. Scientific Reports 2015; 5(1) doi: 10.1038/srep17895
|
| 25 |
Ruby Kasana, Christy Thomas, Gaurav Das, Munlima Hazarika, Krishna Undela. Statin use and risk of cancer. Annals of Oncology Research and Therapy 2023; 3(1): 14 doi: 10.4103/aort.aort_34_22
|
| 26 |
Ali Fatehi Hassanabad, Jonathan V. S. Wong. Statins as Potential Therapeutics for Esophageal Cancer. Journal of Gastrointestinal Cancer 2021; 52(3): 833 doi: 10.1007/s12029-021-00648-4
|
| 27 |
Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan, Giovanni Targher. Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers. Metabolism 2024; 160: 156014 doi: 10.1016/j.metabol.2024.156014
|
| 28 |
Gregoire F. Le Bras, Muhammad H. Farooq, Gary W. Falk, Claudia D. Andl. Esophageal cancer: The latest on chemoprevention and state of the art therapies. Pharmacological Research 2016; 113: 236 doi: 10.1016/j.phrs.2016.08.021
|
| 29 |
ABDULLAH K. ALTWAIRGI. Statins are potential anticancerous agents (Review). Oncology Reports 2015; 33(3): 1019 doi: 10.3892/or.2015.3741
|
| 30 |
Ian L. P. Beales, Leanne Dearman, Inna Vardi, Yoon Loke. Reduced Risk of Barrett’s Esophagus in Statin Users: Case–Control Study and Meta-Analysis. Digestive Diseases and Sciences 2016; 61(1): 238 doi: 10.1007/s10620-015-3869-4
|
| 31 |
S Zhang, X-Q Zhang, X-W Ding, R-K Yang, S-L Huang, F Kastelein, M Bruno, X-J Yu, D Zhou, X-P Zou. Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett’s esophagus: a meta-analysis. British Journal of Cancer 2014; 110(9): 2378 doi: 10.1038/bjc.2014.127
|
| 32 |
Yong Zhang, Weijia Kong, Jiandong Jiang. Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms. Science China Life Sciences 2017; 60(6): 601 doi: 10.1007/s11427-017-9047-4
|
| 33 |
Linda Sleire, Hilde Elise Førde, Inger Anne Netland, Lina Leiss, Bente Sandvei Skeie, Per Øyvind Enger. Drug repurposing in cancer. Pharmacological Research 2017; 124: 74 doi: 10.1016/j.phrs.2017.07.013
|
| 34 |
Gwang Hun Jeong, Keum Hwa Lee, Jong Yeob Kim, Michael Eisenhut, Andreas Kronbichler, Hans J. van der Vliet, Sung Hwi Hong, Jae Il Shin, Gabriele Gamerith. Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2019; 8(6): 819 doi: 10.3390/jcm8060819
|
| 35 |
Motasem Alkhayyat, Prabhat Kumar, Krishna O. Sanaka, Prashanthi N. Thota. Chemoprevention in Barrett’s esophagus and esophageal adenocarcinoma. Therapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211033730
|